Sign inJoin waitlistJoin the waitlist

Giselle Sholler

Division Chief, Pediatric Hematology/Oncology · Penn State Milton S Hershey Medical Center

Credentials: · · · · · ·

History

Pediatric Hematology/Oncology Division · Penn State Milton S Hershey Medical Center
Present
Division of Hematology and Oncology · Penn State Milton S Hershey Medical Center
Present
Penn State Milton S Hershey Medical Center
Present

Pediatric Hematology/Oncology
Rhode Island Hospital/Brown University Health
2002–2005
General Academic Hasbro Children's Hospital
1999–2002
New York Medical College
1995–1999

Research

A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory Neuroblastoma
PLoS ONE · 2015 · First of 22 authors · Corresponding · 125 citations
Eflornithine as Postimmunotherapy Maintenance in High-Risk Neuroblastoma: Externally Controlled, Propensity Score-Matched Survival Outcome Comparisons
Journal of Clinical Oncology · 2024 · Last of 17 authors · Corresponding · 58 citations
A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high-risk neuroblastoma
International Journal of Cancer · 2020 · Last of 18 authors · Corresponding · 53 citations

William Ferguson
9 papers
Jacqueline Kraveka
8 papers
Javier Oesterheld
8 papers
Deanna Mitchell
7 papers
DE
Don Eslin
7 papers
William Roberts
7 papers
R Wada
6 papers
MI
Michael Isakoff
5 papers
Valerie Brown
5 papers
Erin Trovillion
4 papers
JR
Jawhar Rawwas
4 papers
Peter Zage
4 papers

Clinical trials

Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma
Study chair · Recruiting · Phase 2
Milton S. Hershey Medical Center
2026–2036
Preventative Trial of Difluoromethylornithine (DFMO) in High Risk Patients With Neuroblastoma That is in Remission
Study chair · Completed · Phase 2
Giselle Sholler
2015–2023